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Abstract
Background: The relationship between low iodine status and pregnancy-associated comorbidities has been known
for decades. The relationship between iodine intake and placental pathologies is, however, far less clear. This study
was designed to examine the relationship between dietary iodine intake and placental size while also focusing on
typical adverse pregnancy outcomes.
Method: The dietary iodine intake of 4711 pregnant women enrolled in the Czech part of the European
Longitudinal Study of Pregnancy and Childhood (ELSPAC) in 1990–1991 was established using a 145-item
food frequency questionnaire. Multivariate linear regression models were used to estimate the relationship
between dietary iodine intake during pregnancy and placental weight. Additional models were constructed to
investigate the relationship between estimated dietary iodine intake and adverse birth outcomes.
Results: The estimated average iodine intake in the ELSPAC cohort was 106.6 μg/day. In the fully adjusted
model, estimated dietary iodine intake was found to be significantly negatively associated with placental
weight (β = −0.025, 95% CI: -0.044; −0.006, p = 0.011). Moreover, estimated dietary iodine intake was found to
be significantly positively associated with the birth weight / placental weight ratio in the fully adjusted model
(β = −0.024, 95% CI: 0.004; 0.043, p = 0.016).
Conclusions: This study provides evidence of a relationship between estimated dietary iodine intake and
placental weight and the birth weight / placental weight ratio. Additional research is warranted to provide
more insight into the role of iodine in early as well as late placentation.
Keywords: Iodine intake, Placental weight, Birth weight / placental weight, Birth outcome, ELSPAC
Background
Iodine is an essential micronutrient necessary for the
synthesis of thyroid hormones. It has long been recog-
nized that foetal as well as obstetric outcomes are
dependent on normal maternal thyroid function [1]. Se-
vere iodine deficiency during foetal development results
in maternal and foetal hypothyroidism and is associated
with serious adverse health effects, including mainly
cretinism and prenatal as well as postnatal growth re-
tardation [1]. As confirmed many times, thyroid hor-
mones are crucial for the correct development of the
nervous system of the child [2].
Physiologically, gestation calls for significant alterations
in the functioning of the thyroid system, with increased
maternal iodine requirements consequently reaching over
50% [3, 4]. This increase is associated with increasing
foetal demand on thyroid hormones synthesized by the
mother. While the foetus is capable of synthesizing its
own thyroid hormones beginning with the 16th to 20th
week of gestation, during the 8th to 10th week the foetus
utilizes exclusively maternal hormones and is thus fully
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dependent on maternal synthesis at this very early gesta-
tion stage [4–6].
Human chorionic gonadotropin (hCG), a pregnancy-
associated hormone, is involved in the stimulation of the
thyrotropin receptor (TSH-receptor), resulting in the con-
sequent increase in the level of the circulating hormone
leading to suppressed TSH levels via negative feedback. In
addition to hCG, factors directly influencing maternal thy-
roid function include i) increased renal iodine clearance,
ii) estrogen-dependent increase in thyroxine-binding
globulin and iii) placental deiodinase activity. The estab-
lishment of cut-off values for thyroid hormones in preg-
nancy/lactation therefore requires an approach which
takes into account gestational age. Among the above men-
tioned factors, increasing iodine clearance is of consider-
able importance in pregnancy as renal plasma flow
increases by 75% in mid-pregnancy and there is a 50%
higher glomerular filtration rate (GFR) between the first
and third trimesters [7]. The increased renal clearance of
iodine can therefore lead to relatively lower plasma inor-
ganic iodide (PII) concentration, which in turn leads to
higher sodium-iodide symporter activity in the thyroid.
This situation could then lead to increased thyroid iodide
clearance in order to compensate for the relative changes
of plasmatic iodide and mainly to keep the absolute up-
take of iodide within the same range [7].
As iodine is deeply involved in the development and
maintenance of a healthy pregnancy, pregnant women
and their foetuses as well as infants are most vulnerable
to its deficiency. However, there is no unanimous con-
sensus on the issue of iodine supplementation in preg-
nancy. In 2007, the WHO/UNICEF/ICCIDD [8] reached
a limited consensus, stipulating that iodine-containing
supplements should not be recommended to pregnant
women if a given population has been iodine sufficient
for at least two years. More specifically, if the population
in general has an adequate iodine intake with the
median urinary iodine concentration (UIC) ≥100 μg/l
but lower than 150 μg/l, both the American Thyroid
Association [9] and the European Thyroid Association
[10] recommend supplementation. This approach, how-
ever, is not currently advocated by the WHO, which rec-
ommends an iodine intake of 250 μg/day during
pregnancy, with salt iodization listed as the key strategy
suitable for fighting possible deficiencies.
According to the WHO, the Czech Republic now
ranks among countries where iodine deficiency is not
considered a major public health issue. However, the
Central European region has a long history of moder-
ate to severe iodine deficiency. Salt iodisation was
first introduced in Czechoslovakia (now the Czech
Republic) in 1947, with a subsequent dramatic de-
crease in cases of severe iodine deficiency [11]. Me-
dian urinary iodine values in general as well as in
hospitalized adult populations shifted, with initial
values indicating mild iodine deficiency (88–95 μl/l)
prior to 1997, reaching a critical threshold of 100 μl/l
in 1998 and achieving optimal values of 120–140 μl/l
by 2000 [11]. Between 1995 and 2016, urinary iodine
concentration monitoring was conducted in various
population groups, with the most recent study (2015)
observing median urinary iodine concentrations in
pregnant Czech women to be 151 μl/l while approxi-
mately 50% of studied women fulfilled criteria of iod-
ine deficiency [12].
While sufficient information on urine iodine levels is
available, information on dietary iodine intake in the
Czech Republic and its association with public health
risk is very scarce. This study therefore aims to evaluate
the estimated dietary iodine intake in pregnancy in a
large prospective cohort from the European Longitu-
dinal Study of Pregnancy and Childhood (ELSPAC),
contextualize the achieved results with respect to dietary
iodine and investigate the relationship between iodine
intake and defined birth outcomes.
Methods
Study subjects
ELSPAC is a population-based study designed to investi-
gate environmental and other factors affecting the health
and development of children from the prenatal period
until adulthood [13]. The study was initiated as one of six
prospective birth cohort studies by the WHO Regional
Office for Europe in 1985 and was designed to accommo-
date a total of 40,000 children across Europe [14]. The
project was initially coordinated by Bristol University
(Avon Longitudinal Study of Pregnancy and Childhood;
ALSPAC [15]) and included eight independent centres
based in the United Kingdom, Czechoslovakia, Ukraine,
Greece and Russia. In the Czech part of the study, all eli-
gible mothers were living in Brno or Znojmo (cities in
Czechoslovakia) and were expected to deliver between 1
April 1991 and 30 June 1992. A total of 4711 participants
who answered over 50% of the selected questions were
included in the analyses. Approximately 9.7% of all an-
swers were missing and were imputed, as described fur-
ther. A total of 67 women who were on thyroid hormone
replacement or anti-thyroid drugs or who reported thy-
roid disease were excluded from the study.
Ethics statement
Ethical approval for the study was obtained from the
European Longitudinal Study of Pregnancy and Child-
hood (ELSPAC) Law and Ethics committee and local re-
search ethics committees. Written informed consent was
obtained from all study participants and archived.
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Dietary assessment
Participating women were asked to answer two question-
naires during pregnancy, a questionnaire about themselves
(P1 – About You, Mother) and a questionnaire about their
pregnancy (P2 – I am Expecting a Baby). A self-reported
food frequency questionnaire (FFQ) was included as part
of the P2 questionnaire package in accordance with the
ELSPAC protocol [14] at 32 weeks of gestation in 1991–
1992. Based on available domestic and foreign sources as
well as on an expert assessment of portion sizes carried
out by nutrition specialists, a list of individual food items
associated with specific portion sizes which also reflected
the composition of food items in the early 1990s was
developed. The final questionnaire included 145 items in
36 separate food groups. The utilization of domestic
sources allowed us to define portion sizes not only for glo-
bal foods but also for local or regional foods, in accord-
ance with an approach previously used e.g. by the
HAPIEE study [16]. Answers to a total of 44 questions
from the P2 questionnaire were used to calculate iodine
intake. The results of iodine content analysis for individual
items and food groups are provided in Table 1.
Food estimates were combined with iodine content
data from national databases and reported as μg of iod-
ine per 100 g or 100 ml. To achieve a precise and
complete evaluation of iodine intake from all possible
sources, the following databases were used in hierarch-
ical order: Czech Food Composition Database [17],
Slovak Online Food Database [18], National Food Com-
position Database in Finland [19], Danish Food Compos-
ition Databank [20], Composition of Foods Integrated
Dataset (CoFID) [21] and the Nutridan nutritional
programme database [22]. The consumption coefficient
was derived from retrospective food consumption data
based on databases from 1920 to 2006. The average por-
tion was defined for all food item categories with respect
to definitions in view of the fact that portion sizes have
changed throughout the post-communist period, that
weights and volumes of many foods have changed over
time and that current sizes thus cannot be used. Gener-
ally, portion sizes were derived from two domestic
sources from the 1990s: the Verbal and Graphic Formu-
lation of Dietary Guidelines for the Czech Republic pro-
ject [23] and the Czech National Food Consumption
Survey, implemented in the 2003–2006 period [24]. A
weighted average of portion sizes for the entire food
group was then calculated based on the consumption
ratio of individual foods.
Birth outcomes
Selected birth outcomes were treated as dependent vari-
ables in the models: birth length and weight, placental
weight and cephalisation and ponderal indices. Gesta-
tional age, gestational diabetes, gestational hypertension,
stillbirth, congenital malformations, pre-eclampsia and
IVF pregnancy were included as independent variables.
All data were collected by healthcare professionals at the
maternity hospital at the time of birth. Gestational age
was determined using ultrasound dating.
Pre-eclampsia was defined in accordance with the
International Society for the Study of Hypertension in
Pregnancy (ISSHP) criteria [25] as systolic blood pres-
sure ≥ 140 mmHg and/or diastolic blood pressure ≥
90 mmHg along with proteinuria of ≥1+ on urine dip-
stick testing occurring on two occasions after 20 weeks
of gestation. Small for gestational age was defined as be-
ing below the 10th percentile of birth weight adjusted
for gestational age at birth using internal standardisation
by cohort. Preterm birth was defined as birth before
37 weeks of gestation. Gestational diabetes was defined
as any record of a diagnosis of gestational diabetes at
any time during the pregnancy in women without exist-
ing diabetes at the beginning of pregnancy.
Birth weight was measured to a precision of 0.1 kg.
Placental weight was reported by the doctor present at
birth. All possible gestational complications were sum-
marised in the physician’s birth questionnaire (N1). The
ponderal index was calculated as birth weight (kg)
divided by birth length cubed (m3). The cephalisation
index was expressed as the ratio of head circumference
at birth (cm × 104) to birth weight (g) and later
expressed as μm/g [26].
Covariates
Several variables may be considered to constitute potential
confounding factors for the investigated birth outcomes.
In order to construct statistical models for defined birth
outcomes, the following independent variables were
included in the analyses, as appropriate: dichotomised co-
morbidities in present and previous pregnancies (gesta-
tional diabetes at present, pre-eclampsia, gestational
hypertension associated with a current pregnancy, still-
birth occurring in the past, in vitro fertilization associated
with a current pregnancy and congenital malformations in
the past), gestational age, maternal pre-conceptional
weight, maternal age at birth, maternal smoking prior to
pregnancy (never smoker, smoker in the past, smoker in
the last nine months), living with partner status (yes–no),
self-reported alcohol intake during pregnancy and self-
reported drug abuse during pregnancy. Maternal socio-
economic status, a variable generally associated with
adverse birth outcomes, was assessed based on several
variables: maternal education (categorized according to
ISCED), maternal job (categorized according to ISCO 88
and ISCO 08 into 16 groups and 4 skill levels), ethnicity
(Caucasian, other) and family income calculated according
to Eurostat recommendations for equalized family income
[27], and appropriately adjusted to. Since extreme
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Table 1 Estimated iodine content in selected items/groups
List of food groups Food item Iodine content
















































Sausages smoked meat 7.8
frankfurters
sausages
Table 1 Estimated iodine content in selected items/groups
(Continued)
List of food groups Food item Iodine content

























Fried potatoes French fries 3.6
Roasted potatoes 9.0
Boiled potatoes boiled potatoes 9.3
mashed potatoes
Pasta 9.0
Rice cooked rice 3.0
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maternal height may sometimes be associated with an in-
creased risk of adverse birth outcomes, all models were
adjusted to also accommodate maternal height. Moreover,
as advanced maternal age as well as offspring gender may
be associated with worse obstetric outcomes, adjustments
taking into account maternal age at birth as well as child
gender were also made.
Statistical modelling
Dietary iodine intake was analysed using 44 food items
with established iodine content selected from FFQs
administered to study subjects. Uniformity was tested by
examining the distribution of variables in a loading plot
verified using the Kaiser-Meyer-Olkin (KMO) measure-
ment of adequacy with a value of 0.5 considered as
acceptable for further analysis. The Bartlett sphericity
test was used to establish whether the correlation matrix
differed significantly from the identity matrix [28]. Or-
thogonal varimax rotation was used to minimize the
number of indicators which might have high loading on
one factor [29].
The relationship between maternal dietary iodine
intake and birth outcomes was investigated using lin-
ear regression models. Multivariate models were built
for each birth outcome separately in two steps. First,
the association between maternal dietary iodine intake
and birth outcomes was investigated using a crude
unadjusted analysis using the univariate models. Sec-
ond, biological factors (maternal height, paternal
height, maternal preconception weight and maternal
age), social and demographic characteristics (maternal
and paternal education, ethnicity, occupation, equal-
ized family income), maternal health and comorbidi-
ties of the mother and child (gestational diabetes,
gestational hypertension, stillbirth, child congenital
malformations, IVF pregnancy and pre-eclampsia),
maternal alcohol consumption, substance abuse,
smoking and use of nutritional supplements during
pregnancy, and finally gestational age and sex of the
child were included as potential confounders into
final (adjusted) multivariate models.
Missing data were imputed using the Multiple Imput-
ation by Chained Equations method [30] and regression
models were built using imputed data. All analyses were
performed using R, version 3.1.2 and STATA, version




The basic anthropometric and demographic characteris-
tics of the study subjects are provided in Table 2.
Dietary patterns
Food group analysis was performed using factor analysis.
The adequacy of data for analysis was evaluated based
on the KMO value [31]; the result of Bartlett’s sphericity
test (χ2 = 14,435, df = 630, p < 0.001) provided strong
statistical evidence that the correlation matrix was sig-
nificantly different from the identity matrix.
Three factors identified in pregnant women explained
14.6% of total variance. The first factor – which
accounted for 6.2% of total variance among mothers –
was labelled the prudent factor. This factor may be char-
acterized by high factor loading in the case of whole-
wheat bakery products, fish, legumes, fresh vegetables,
root vegetables and rice. The second factor – which
accounted for 4.5% of total variance – was labelled the
carbohydrate–dairy factor and included foods such as
refined flour bakery products, pudding, cheese, fresh
fruit, milk and dairy products. The third factor – which
accounted for 3.9% of total variance – was labelled the
junk food factor and included items such as biscuits, wa-
fers, pies and cakes, French fries, roasted potatoes, pâté
and ground meat. The factors scores of the individual
patterns have been reported in our previous paper focus-
ing on the association of anthropometry with dietary
patterns of mothers in the third trimester [32].
Table 1 Estimated iodine content in selected items/groups
(Continued)
List of food groups Food item Iodine content
[μg/100 g or 100 ml]



















Soft drinks lemonade 3.2
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Estimated iodine intake and birth outcomes
In order to address the potential association between
estimated iodine intake and placental size in the context
of birth outcomes, we first performed an estimation of
average dietary iodine intake by assigning average iodine
intake to individual food items. Since no longitudinal
comprehensive Czech database providing measured iod-
ine levels for a broad spectrum of foods in the relevant
period (1991–1992) is currently available, we derived
iodine intake data from multiple available databases and
systematically contextualized iodine content with indi-
vidual FFQ items. As considerable differences in re-
ported iodine intake between databases from various
geographical regions were established, we based our
methodology on the origin of iodine in foods in close
geographical regions. For example, while the Czech Food
Composition Database [17] reported values of iodine
content in fish to be 0–4.1 μg/100 g, the National Food
Composition Database in Finland [33] reported a value
of 105 μg/100 g and the Danish Food Composition
Databank [34] reported a value of 253 μg/100 g. In such
cases, we used values from the database from a geo-
graphical region closest to the Czech Republic. While
the highest iodine content was reported for infant for-
mula, powdered soups, smoked fish, canned meat and
sausages, milk and saltwater fish, the most frequently
consumed and thus most important dietary sources
included milk, baked goods, eggs, saltwater fish, pota-
toes, pasta and yoghurt [35]. The high dietary exposure
to iodine from animal sources is the result of massive
iodine supplementation of animal feed in the case of ani-
mals destined for meat and egg production, ongoing
throughout the study period.
Once various birth outcomes included in the initial
model were reduced to dependent variables, we obtained
a single final model with a statistically significant rela-
tionship between estimated iodine intake and placental
weight. We observed a negative association which indi-
cates that every 100 μg of daily iodine intake during
pregnancy is significantly associated with a 2.5%
decrease in placental weight (95% CI: 0.6;4.3%).
Quartiles of cohort subjects with respect to estimated
iodine intake are provided in Table 3. Models for other
outcomes including e.g. birth weight were non-significant
and are not discussed further. The results of univariate as
well as multivariate regression modelling for the logarithm
of placental weight are provided in Table 4. The table
shows the estimated coefficients of linear regression in un-
adjusted (univariate) and fully adjusted (multivariate)
models for the effects of maternal dietary iodine intake
and other covariates on placental weight. Results with
other birth outcomes as dependent variables are not
Table 2 Basic anthropometric/demographic characteristics of the study subjects
variable unit mean sd median 5th perc. 95th perc. min max
Iodine intake μg/day 106.6 42.4 101.1 49.2 175.6 6.7 612.5
Family income CZK/month 5490 2490 5000 2600 9000 1500 48,000
Equalized family size person 2.2 0.6 2.1 1.8 3.3 1.0 10.5
Equivalized family income CZK/month 2596 1286 2478 1071 4444 364 26,667
Maternal age y 25.2 4.8 24.6 18.8 34.7 15.2 48.7
Gestational age week 39.7 1.7 39.9 36.7 41.9 23.1 44.6
Birth length cm 50.2 2.3 50.0 46.0 53.0 30.0 59.0
Birth weight g 3290 493 3300 2500 4050 600 5350
Placental weight g 587 164 560 380 860 115 1500
Head circumference cm 34.6 1.4 35.0 32.0 37.0 23.0 43.0
Cephalisation index μm/g 107.2 17.6 104.7 87.7 133.3 60.7 500.0
Ponderal index kg/m3 25.9 2.3 25.8 22.5 29.6 16.3 49.3
Birth weight / Placental weight – 5.9 1.6 5.8 3.7 8.9 1.5 17.3
Maternal height cm 166.3 6.0 167.0 157.0 176.0 135.0 189.0
Paternal height cm 179.6 6.8 180.0 169.0 191.0 152.0 204.0
Maternal preconc. weight kg 61.0 9.9 60.0 48.0 80.0 38.0 135.0
Maternal preconc. BMI kg/m2 22.0 3.3 21.5 18.1 28.3 15.1 46.1
Energy intake kJ/day 6558 2157 6272 3563 10,273 2504 19,362
FS Prudent – 0.0 1.0 −0.1 −1.4 1.9 −2.1 3.9
FS Carbohydrates – 0.0 1.0 −0.1 −1.5 1.8 −3.1 3.5
FS Junk food – 0.0 1.0 −0.1 −1.5 1.8 −2.8 3.7
Bienertová-Vašků et al. Nutrition & Metabolism  (2018) 15:5 Page 6 of 14
shown as no significant associations with dietary iodine
were observed. In the final model for the natural logarithm
of placental weight, dietary estimated iodine intake was
found to be a significant predictor of logarithm of placental
weight (β = −0.025, 95% CI: -0.044; −0.006, p = 0.011).
Estimated iodine intake and birth weight / placental
weight ratio
The results of univariate as well as multivariate regres-
sion modelling for the logarithm of birth weight / pla-
cental weight ratio are provided in Table 5.
Discussion
Multiple physiological changes in thyroid function take
place during pregnancy; aberrant thyroid function dur-
ing pregnancy has been associated with adverse obstetric
outcomes [36]. Since the adverse impact of thyroid dys-
function on foetal development and obstetric outcomes
has been empirically observed for decades, the issue of
whether to screen for maternal thyroid dysfunction ante-
natally or preconceptionally or not is subject to an
ongoing debate which has yet to be resolved in a satis-
factory way. Furthermore, supplementation guidelines
are also being debated worldwide. However, insufficient
information is currently available on the role of iodine
dietary intake on birth outcomes and subsequent child
development, especially as most studies focus on the ef-
fects of supplementation and not on modified dietary
composition. Exceptions include studies by Bath et al.
[37], Hynes et al. [38] and Abel et al. [39], which report
that even a mild degree of iodine deficiency in preg-
nancy is associated with verbal IQ, reading accuracy and
reading comprehension at 8 years [37], educational out-
comes at 9 years [38] and child language delay, behav-
ioural problems and reduced fine motor skills at 3 years
of age [39].
Based on our results, iodine intake may potentially
change the weight of the placenta or the birth weight /
placental weight ratio by several percent. This supports
a hypothesis which states that the placenta may serve to
some extent as an iodine reservoir capable of expanding
in size to increase its absorption potential in the case of
lower dietary iodine intake, i.e. in a manner similar to
the thyroid gland. The same association of iodine intake
and placental size has been observed in mice [40]. Based
on empirical observations of the detrimental effects of
inadequate or excessive dietary iodine intake during
pregnancy for foetal development and/or birth outcomes
both for the mother and the child, it can be speculated
that only a narrow range of optimum iodine levels leads
to optimum outcomes. An existing animal study has
reported the linear association of increasing toxicity with
increasing dietary iodine intake and the association of
decreasing placenta size with the linear growth of dietary
iodine [40], which thus supports the hypothesis that ma-
ternal thyroid hormones are directly involved in placen-
tal growth and development control.
The above mentioned findings are in line with the
current understanding of the role of the trophoblast in
the regulation of iodine and thyroid hormone transfer
from the mother to the foetus. While the foetal thyroid
starts to concentrate iodine after the first 10–12 weeks
of gestation, the synthesis and secretion of the thyroid
hormone under TSH control starts at approximately
20 weeks of gestation [41]. Prior to the beginning of the
autonomous synthesis of thyroid hormones, the foetus
fully relies on maternal thyroxine and utilizes both T3
and T4 to stimulate EGF production by primary cytotro-
phoblasts, thus promoting their survival [42]. Transpla-
cental transport of maternal thyroid hormones is
supported by the evidence of biologically significant con-
centrations of free thyroxine (t4) in foetal coelomic fluid,
while these concentrations are highly independent on
the thyroid of the offspring (in foetuses with absent thy-
roid, up to 50% of normal concentrations of t4 can be
observed) [43].
The transplacental passage of thyroid hormones from
mother to foetus and the following supply of the thyroid
hormones into trophoblast cells requires the expression
of placental plasma membrane transporters for thyroid
hormones. The human placenta displays a wide range of
transporters for thyroid hormones from early gestation:
Table 3 Quartiles of study subjects in relation to birth outcomes and estimated iodine intake (as mean ± sd)










Birth length [cm] 50.1 ± 2.3 50.2 ± 2.2 50.3 ± 2.3 50.1 ± 2.3 0.112
Birth weight [g] 3288 ± 470 3287 ± 470 3325 ± 493a 3263 ± 501a 0.035
Placental weight [g] 591 ± 168 595 ± 167a 587 ± 166 576 ± 163a 0.035
Cephalisation index [μm/g] 107.5 ± 20.1 107.1 ± 16.4 106.0 ± 16.8a 108.0 ± 17.3a 0.059
Ponderal index [kg/m3] 25.9 ± 2.2 25.9 ± 2.5 26.0 ± 2.3 25.8 ± 2.2 0.266
Birth weight/Placental weight [−] 5.9 ± 1.6 5.9 ± 1.6 6.0 ± 1.55 6.0 ± 1.6 0.083
asignificant differences between means in post-hoc analysis using Tukey-Kramer method
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Table 4 The effects of iodine intake and other covariates on natural logarithm of placental weight in univariate and multivariate
models
Univariate models Multivariate model
β estimate 95% CI for β estimate p-value β estimate 95% CI for β estimate p-value
Iodine intake [100 μg/day] −0.032 (−0.050; −0.013) <0.001 −0.025 (−0.044; −0.006) 0.011
Gestational diabetes
No (ref) (ref)
Yes −0.088 (−0.149; −0.027) 0.005 −0.080 (−0.140; −0.020) 0.009
Pre-eclampsia
No (ref) (ref)
Yes −0.105 (−0.208; −0.002) 0.046 −0.133 (−0.234; −0.031) 0.011
Gestational hypertension
No (ref) (ref)
Yes 0.062 (0.010; 0.113) 0.019 0.053 (0.001; 0.104) 0.046
Gestational age [w] 0.015 (0.010; 0.019) <0.001 0.013 (0.009; 0.018) <0.001
Stillborn
No (ref) (ref)
Yes −0.064 (−0.149; 0.022) 0.143 −0.056 (−0.140; 0.028) 0.193
IVF pregnancy
No (ref) (ref)
Yes 0.131 (0.041; 0.220) 0.004 0.141 (0.051; 0.230) 0.002
Congenital malformations
No (ref) (ref)
Yes 0.016 (−0.025; 0.057) 0.453 0.016 (−0.025; 0.056) 0.443
Smoking
Never (ref) (ref)
Past smoker 0.012 (−0.005; 0.029) 0.152 0.008 (−0.009; 0.025) 0.353
Current smoker −0.024 (−0.052; 0.005) 0.100 −0.019 (−0.049; 0.011) 0.206
Substance abuse
No (ref) (ref)
Yes −0.050 (−0.134; 0.034) 0.239 −0.033 (−0.116; 0.051) 0.443
Alcohol
No (ref) (ref)
Yes −0.018 (−0.048; 0.013) 0.261 −0.020 (−0.050; 0.011) 0.213
Nutritional supplements
No (ref) (ref)
Yes 0.050 (0.035; 0.066) <0.001 0.047 (0.031; 0.063) <0.001
ISCO skill level - mother
Skill level 1 (ref) (ref)
Skill level 2 0.005 (−0.031; 0.040) 0.805 0.001 (−0.036; 0.037) 0.978
Skill level 3 −0.009 (−0.048; 0.030) 0.639 −0.015 (−0.056; 0.027) 0.493
Skill level 4 −0.006 (−0.043; 0.031) 0.741 −0.014 (−0.055; 0.027) 0.506
Skill level unassigned −0.051 (−0.176; 0.075) 0.428 −0.056 (−0.179; 0.068) 0.377
ISCO skill level - father
Skill level 1 (ref) (ref)
Skill level 2 −0.006 (−0.059; 0.046) 0.814 −0.007 (−0.059; 0.044) 0.783
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MCT8, MCT10, LAT1, LAT2, OATP1A2 and OATP4A1;
the observed expression patterns are different between
pregnancies with normal physiology and pregnancies af-
fected with intrauterine growth restriction [44]. These
transporters have been recently shown to accumulate iod-
ine in the placental cell lines and are generally upregulated
by hCG [44].
The delivery of the maternal thyroid hormones to the
foetus therefore depends on i) the availability of the thy-
roid hormones in the maternal circulation and ii) the
functional effectiveness of the transplacental transport
systems. Current knowledge of thyroid hormone trans-
porters not only strongly suggests that the placenta plays
a role in iodine uptake, but also supports the hypothesis
that the placenta may act as a storage capacity supplying
iodine to the foetus gradually [45]. This is supported by
recently established evidence which indicates that pla-
cental iodine uptake is saturable, which is typical of the
thyroid gland [46]. To conclude, while the thyroid has a
demonstrably greater capacity for iodide update than the
placenta, the placenta and thyroid appear to share nu-
merous iodine uptake and efflux mechanisms [45].
The exact mechanism and reason for decreasing
placental size with increasing dietary iodine is, however,
unknown and deserves further investigation. Although
the importance of aberrant placental size is generally
unclear, some evidence indicates that placental size may
be associated with future developmental/cardiometabolic
conditions. Some studies suggest that placental size is
correlated with birth weight as well as with placental
function [47]. Under certain conditions, e.g. malnutri-
tion, the placental surface may increase in order to
obtain more nutrients for the foetus, which may in turn
result in increased placental weight at birth [48, 49]. On
the whole, while a small placenta has previously been as-
sociated with premature birth risk, increased placental
size has been associated with an increased rate of
adverse conditions in newborns [50]. Some studies also
Table 4 The effects of iodine intake and other covariates on natural logarithm of placental weight in univariate and multivariate
models (Continued)
Univariate models Multivariate model
β estimate 95% CI for β estimate p-value β estimate 95% CI for β estimate p-value
Skill level 3 −0.026 (−0.083; 0.031) 0.369 −0.019 (−0.076; 0.038) 0.508
Skill level 4 −0.013 (−0.066; 0.041) 0.641 0.010 (−0.046; 0.065) 0.734
Skill level unassigned 0.004 (−0.056; 0.064) 0.894 0.026 (−0.033; 0.085) 0.386
Education – mother
Basic (ref) (ref)
Secondary 0.005 (−0.012; 0.023) 0.529 0.022 (0.002; 0.043) 0.035
University and higher 0.000 (−0.021; 0.022) 0.977 0.033 (0.001; 0.065) 0.043
Education – father
Basic (ref) (ref)
Secondary −0.001 (−0.021; 0.018) 0.880 −0.001 (−0.023; 0.021) 0.936
University and higher −0.016 (−0.035; 0.003) 0.090 −0.025 (−0.054; 0.004) 0.091
Equalized family intake [1000 CZK/month] −0.002 (−0.011; 0.008) 0.698 −0.002 (−0.012; 0.009) 0.732
Age - mother [y] 0.001 (−0.001; 0.002) 0.377 0.000 (−0.001; 0.002) 0.669
Height - mother [cm] 0.002 (0.000; 0.003) 0.012 0.002 (0.000; 0.003) 0.014
Height - father [cm] 0.000 (−0.001; 0.001) 0.973 0.000 (−0.002; 0.001) 0.501
Maternal preconceptional BMI [kg/m2] 0.008 (0.006; 0.010) <0.001 0.007 (0.005; 0.010) <0.001
Ethnicity – mother
European (ref) (ref)
Others −0.029 (−0.100; 0.042) 0.429 0.020 (−0.063; 0.104) 0.632
Ethnicity – father
European (ref) (ref)
Others −0.039 (−0.094; 0.016) 0.168 −0.018 (−0.083; 0.047) 0.591
Sex of the child
Girl (ref) (ref)
Boy 0.029 (0.014; 0.045) <0.001 0.029 (0.014; 0.045) <0.001
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Table 5 The effects of iodine intake and other covariates on natural logarithm of birth weight/placental weight ratio in univariate
and multivariate models
Univariate models Multivariate model
β estimate 95% CI for β estimate p-value β estimate 95% CI for β estimate p-value
Iodine intake [100 μg/day] 0.015 (−0.005; 0.035) 0.136 0.024 (0.004; 0.043) 0.016
Gestational diabetes
No (ref) (ref)
Yes 0.093 (0.030; 0.156) 0.004 0.106 (0.045; 0.167) <0.001
Pre-eclampsia
No (ref) (ref)
Yes 0.008 (−0.100; 0.116) 0.883 0.039 (−0.065; 0.143) 0.460
Gestational hypertension
No (ref) (ref)
Yes −0.099 (−0.153; −0.045) <0.001 −0.085 (−0.138; −0.032) 0.002
Gestational age [w] 0.042 (0.037; 0.046) <0.001 0.041 (0.036; 0.046) <0.001
Stillborn
No (ref) (ref)
Yes −0.008 (−0.097; 0.081) 0.860 0.008 (−0.076; 0.092) 0.848
IVF pregnancy
No (ref) (ref)
Yes −0.116 (−0.210; −0.023) 0.015 −0.126 (−0.216; −0.037) 0.006
Congenital malformations
No (ref) (ref)
Yes −0.029 (−0.071; 0.013) 0.179 −0.035 (−0.075; 0.006) 0.095
Smoking
Never (ref) (ref)
Past smoker −0.012 (−0.029; 0.005) 0.178 −0.012 (−0.029; 0.005) 0.172
Current smoker −0.031 (−0.060; −0.002) 0.039 −0.019 (−0.049; 0.011) 0.215
Substance abuse
No (ref) (ref)
Yes −0.029 (−0.113; 0.056) 0.501 0.000 (−0.083; 0.083) 0.998
Alcohol
No (ref) (ref)
Yes 0.015 (−0.018; 0.048) 0.372 0.016 (−0.015; 0.046) 0.317
Nutritional supplements
No (ref) (ref)
Yes −0.050 (−0.066; −0.034) <0.001 −0.045 (−0.061; −0.028) <0.001
ISCO skill level - mother
Skill level 1 (ref) (ref)
Skill level 2 0.009 (−0.028; 0.047) 0.634 0.006 (−0.031; 0.042) 0.764
Skill level 3 0.029 (−0.011; 0.070) 0.160 0.016 (−0.026; 0.058) 0.444
Skill level 4 0.039 (0.000; 0.078) 0.047 0.019 (−0.022; 0.061) 0.364
Skill level unassigned 0.018 (−0.111; 0.147) 0.786 0.031 (−0.093; 0.155) 0.621
ISCO skill level - father
Skill level 1 (ref) (ref)
Skill level 2 0.021 (−0.034; 0.076) 0.449 0.010 (−0.043; 0.063) 0.709
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associate placental size and weight with cardiometabolic
risks later in life, e.g. with the risk of hypertension [51]
or with total bone mass [52]. The association of placen-
tal size with bone mass and density is of special interest,
as it was identified in ALSPAC, the mirror cohort to
ELSPAC. However, any interpretation of such results
between various ethnic groups and populations is com-
plicated [53] and requires further investigation.
The gold standard for the estimation of iodine status
in the general population today is urinary iodine concen-
tration measurement [54]. Studies focusing on the asso-
ciation of urinary iodine concentration and dietary
iodine intake are scarce and generally conclude that
women with smaller placental size are more frequently
prone to iodine deficiency [55]. A 2011 study comparing
Irish and Iranian women, however, established differ-
ences between these two populations with respect to the
ratio of placental iodine and urinary iodine concentra-
tion [46]. Based on this observation, it could be
hypothesized that the placenta may act as a thus far
unrecognized iodine reservoir designed to ensure the
physiological development of the foetus despite fluctua-
tions in dietary iodine.
At the time of data collection, recommended daily iod-
ine intake was generally 50–100 μg/day with 150 μg/day
recommended for pregnant women [56]. The recom-
mendation substantially changed over time, with recom-
mended daily intake established at 150 μg/day for the
non-pregnant population and 250 μg/day for pregnant
or breastfeeding women. While recommended daily iod-
ine intake for the non-pregnant population can be
achieved quite easily, most pregnant/breastfeeding
women are unable to achieve the recommended levels of
iodine in their diet [11]. In this study, we report that
estimated iodine intake levels in pregnant women are
below the recommended levels both for the early 1990s
as well as for 2016, i.e. in line with previous observations
conducted on smaller population samples. In a very
Table 5 The effects of iodine intake and other covariates on natural logarithm of birth weight/placental weight ratio in univariate
and multivariate models (Continued)
Univariate models Multivariate model
β estimate 95% CI for β estimate p-value β estimate 95% CI for β estimate p-value
Skill level 3 0.037 (−0.023; 0.097) 0.225 0.007 (−0.052; 0.067) 0.816
Skill level 4 0.039 (−0.016; 0.095) 0.162 −0.012 (−0.069; 0.045) 0.688
Skill level unassigned −0.027 (−0.088; 0.033) 0.378 −0.038 (−0.097; 0.021) 0.206
Education – mother
Basic (ref) (ref)
Secondary 0.013 (−0.005; 0.030) 0.164 −0.019 (−0.040; 0.002) 0.081
University and higher 0.030 (0.008; 0.053) 0.009 −0.029 (−0.062; 0.004) 0.081
Education – father
Basic (ref) (ref)
Secondary 0.017 (−0.003; 0.037) 0.092 0.009 (−0.014; 0.031) 0.444
University and higher 0.036 (0.016; 0.055) <0.001 0.030 (0.000; 0.060) 0.047
Equalized family intake [1000 CZK/month] 0.009 (−0.001; 0.019) 0.080 0.005 (−0.006; 0.016) 0.382
Age - mother [y] 0.002 (0.000; 0.003) 0.048 0.001 (−0.001; 0.003) 0.463
Height - mother [cm] 0.003 (0.002; 0.004) <0.001 0.001 (0.000; 0.003) 0.059
Height - father [cm] 0.002 (0.001; 0.004) <0.001 0.001 (0.000; 0.003) 0.028
Maternal preconceptional BMI [kg/m2] −0.001 (−0.004; 0.001) 0.238 −0.001 (−0.004; 0.001) 0.345
Ethnicity – mother
European (ref) (ref)
Others −0.075 (−0.150; −0.001) 0.048 −0.012 (−0.098; 0.073) 0.780
Ethnicity – father
European (ref) (ref)
Others −0.037 (−0.094; 0.020) 0.204 0.011 (−0.054; 0.075) 0.740
Sex of the child
Girl (ref) (ref)
Boy 0.016 (0.000; 0.032) 0.051 0.014 (−0.001; 0.029) 0.076
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recent study using the same Central European popula-
tion, urinary iodine values of over 150 μg/l, i.e. comply-
ing with WHO requirements for pregnant women, were
only found in 30% of the total of 750 examined Czech
pregnant women [57] with the median urinary iodine
concentration above 151 μg/l. This implies that no sig-
nificant improvement in supplementation has taken
place over time (our results originating in the early
1990s are in line with very recent observations). Based
on our results, the proper management of latent iodine
deficiency seems to constitute a major public health
issue in the Czech Republic.
Strengths and limitations
The major limitation of the study is that due to the design
of the study (no biological samples were available for this
cohort) we were unable to carry out adjustments for urin-
ary iodine. Due to the large number of subjects, it was
necessary to use food frequency questionnaires which
were not formally calibrated against diet diaries or bio-
markers, i.e. a common approach in the early 1990s. Since
the FFQ constitutes a methodological instrument designed
to measure long-term dietary behaviour, it is prone to sev-
eral methodological limitations, including a finite list of
foods and food groups [58]. Finally, it is possible that due
to the retrospective nature of the questionnaire, some
memory bias was introduced when compared with a pro-
spective food records-based methodology.
On the other hand, it must be mentioned that this study
is the first to investigate dietary iodine intake in relation to
the dietary patterns of pregnant women in the transitional
period of the early 1990s in Czechoslovakia. Moreover, it
also provides insight into the significant relationship be-
tween dietary estimated iodine intake and defined adverse
birth outcomes. Additional key points of this study
include the relatively large sample size of pregnant women
and multiple adjustment for confounding factors, al-
though the possibility of residual confounding can never
be entirely ruled out. In addition, the observed dietary pat-
terns are consistent with patterns expected in early 1990s
Czechoslovakia, which may be demonstrated e.g. by the
absence of typical “imported” patterns such as Mediterra-
nean and vegetarian diets not typical at the time.
Conclusion
This study reveals the possible influence of dietary iod-
ine intake and its effect on placenta size, which influ-
ences the dynamics of intrauterine growth. These results
contribute to the much-needed debate on iodine intake
during the vulnerable child development period. Follow-
ing adjustment for multiple confounders, including
socio-economic status, our study found placental weight
to be the only birth outcome significantly associated
with iodine intake. While our research indicates that the
placenta may be partially capable of compensating for
iodine deficiency, more research into mechanistic rela-
tionship between iodine accumulation and placental
growth is necessary. Based on our results, however, we
encourage researchers to use placental weight as a pos-
sible interaction parameter with iodine supplementation
in future studies.
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